Lighthouse Financial’s Vertex Pharmaceuticals VRTX Stock Holding History

Lighthouse Financial’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$5.18M	Buy	9,910 +3,395	+52%	+$1.74M	2.33%	12
2026 Q2	$3.24M	Buy	6,515 +238	+4%	+$105K	1.68%	19
2026 Q1	$2.8M	Buy	6,277 +2,547	+68%	+$1.19M	1.69%	18
2025 Q4	$1.69M	Hold	3,730	–	–	1.11%	21
2025 Q3	$1.46M	Hold	3,730	–	–	0.96%	22
2025 Q2	$1.66M	Hold	3,730	–	–	1.27%	20
2025 Q1	$1.81M	Buy	3,730 +25	+0.7%	+$11.6K	1.56%	16
2024 Q4	$1.49M	Buy	+3,705	New	+$1.72M	1.21%	21

Other funds holding VRTX

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

AMF Tjänstepension Stockholm, Sweden $17.2B AUM 28.3% 1-Year Est. Return

Bank Julius Baer & Co Zurich, Switzerland $39.3B AUM 31.81% 1-Year Est. Return

ProShare Advisors Bethesda, Maryland $69.5B AUM 31.38% 1-Year Est. Return

Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $57B AUM 43.56% 1-Year Est. Return

Davenport & Co Richmond, Virginia $19.9B AUM 12.67% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

Lighthouse Financial's VRTX Position: Q3 2026 in Review

Lighthouse Financial increased its Vertex Pharmaceuticals (VRTX) stake by 52% in Q3 2026, buying an estimated $1.74M and bringing the position to 9,910 shares worth $5.18M. The position accounts for 2.33% of the portfolio, ranked #12.

Lighthouse Financial first reported a position in VRTX in Q4 2024 and has held it in 8 quarters since. 700 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.

Lighthouse Financial held 9,910 shares of Vertex Pharmaceuticals worth $5.18M as of Q3 2026.
Lighthouse Financial bought 3,395 Vertex Pharmaceuticals shares in Q3 2026, an estimated $1.74M.
Vertex Pharmaceuticals made up 2.33% of Lighthouse Financial's portfolio in Q3 2026, its #12 holding.
Lighthouse Financial first reported a position in Vertex Pharmaceuticals in Q4 2024 and has held it in 8 quarters since.
700 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.

Based on Lighthouse Financial's 13F filing for Q3 2026, filed 23 Oct 2026.